Bharat Biotech
-

Bharat Biotech ‘inadvertently missed’ including ICMR, NIV as co-developers in Covaxin patent: Centre
Scroll Staff
-

‘Inadvertent mistake,’ says Bharat Biotech on why it failed to credit ICMR in Covaxin patent filings
Scroll Staff
-

ICMR demands international journal withdraw study by Indian researchers on safety of Covaxin
Scroll Staff
-

Covaxin has ‘excellent track record’, says Bharat Biotech after study details side effects
Scroll Staff
-

Covaxin maker Bharat Biotech, linked firms gave Rs 25 crore to TDP even though it is out of power
Anjana Meenakshi Project Electoral Bond
-

Coronavirus: Mansukh Mandaviya launches India’s first intranasal vaccine
Scroll Staff
-

Covid-19: Bharat Biotech to launch intranasal vaccine on January 26
Scroll Staff
-

Covid-19: Bharat Biotech’s intranasal vaccine gets emergency use approval
Scroll Staff
-

Coronavirus: Bharat Biotech says its intranasal vaccine is safe, generates immune response
Scroll Staff
-

Bharat Biotech must address WHO suspension on procuring Covaxin through UN, says foreign ministry
Scroll Staff
-

WHO suspends Covaxin supply through United Nations agencies citing manufacturing deficiencies
Scroll Staff
-

The big news: Nawab Malik sent to ED custody till March 3, and nine other top stories
Scroll Staff
-

‘The Wire’ says Bharat Biotech did not serve notice before filing defamation case
Scroll Staff
-

The big news: Kerala reports more than 54,000 Covid cases, and nine other top stories
Scroll Staff
-

Bharat Biotech gets approval to conduct trials for its intranasal Covid-19 booster dose
Scroll Staff
-

Covaxin booster dose neutralises both Delta and Omicron variants, says Bharat Biotech
Scroll Staff
-

No proof of Covaxin’s efficacy against Omicron strain in Bharat Biotech’s study on booster dose
Scroll Staff
-

Covaxin has shown good immune response among children, says Covid panel chief
Scroll Staff
-

Covaxin receives DCGI approval for use in children from 12 to 18 years
Scroll Staff
-

Covaxin shows 50% efficacy against symptomatic cases of coronavirus: Lancet study
Scroll Staff